Cardiac Positron Emission Tomography: Viability, Perfusion, Receptors and Cardiomyopathy
Myocardial viability has become one of the most important issues in clinical cardiology. In particular, absence or presence of viability may be decisive in patient management, and the decision to perform angioplasty (PTCA) or bypass surgery (CABG) is frequently based on the accurate assessment of vi...
Gespeichert in:
Weitere Verfasser: | , , , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Dordrecht
Springer Netherlands
1995
|
Schriftenreihe: | Developments in Cardiovascular Medicine
166 |
Schlagworte: | |
Online-Zugang: | UBR01 Volltext |
Zusammenfassung: | Myocardial viability has become one of the most important issues in clinical cardiology. In particular, absence or presence of viability may be decisive in patient management, and the decision to perform angioplasty (PTCA) or bypass surgery (CABG) is frequently based on the accurate assessment of viability. Although echocardiography and conventional nuclear medicine techniques may provide valuable information on viability, positron emission tomography (PET) is currently considered to be the gold standard for the assessment of myocardial viability. The simultaneous evaluation of myocardial metabolism and perfusion allows precise delineation and accurate quantification of residual myocardial viability in affected regions. In addition, accurate quantification of myocardial perfusion alone may provide insight into the basic mechanisms of syndrome X and may assist in the appropriate clarification of this clinically complicated, but frequently occurring phenomenon. Besides that, cardiac PET may deepen our insight into metabolism and perfusion of cardiac muscle disease, particularly in hypertrophic cardiomyopathy. Furthermore, receptor imaging studies with PET will become important as the study of cardiac neurohumoral regulation in heart failure has gained in interest. Cardiac Positron Emission Tomography: Viability, Perfusion, Receptors and Cardiomyopathy describes the most recent developments in cardiac PET as these are related to myocardial viability and myocardial perfusion studies of syndrome X. The value of PET for receptor imaging and cardiac muscle disease is also discussed. For cardiologists, nuclear medicine physicians, radiochemists, physiologists, technicians and basic researchers interested in understanding the most recent achievements in cardiovascular PET. |
Beschreibung: | 1 Online-Ressource (XVI, 256 p) |
ISBN: | 9789401100236 |
DOI: | 10.1007/978-94-011-0023-6 |
Internformat
MARC
LEADER | 00000nmm a2200000zcb4500 | ||
---|---|---|---|
001 | BV046144065 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 190905s1995 |||| o||u| ||||||eng d | ||
020 | |a 9789401100236 |9 978-94-011-0023-6 | ||
024 | 7 | |a 10.1007/978-94-011-0023-6 |2 doi | |
035 | |a (ZDB-2-SME)978-94-011-0023-6 | ||
035 | |a (OCoLC)1119081868 | ||
035 | |a (DE-599)BVBBV046144065 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 616.12 |2 23 | |
084 | |a YR 5000 |0 (DE-625)154117:12905 |2 rvk | ||
245 | 1 | 0 | |a Cardiac Positron Emission Tomography |b Viability, Perfusion, Receptors and Cardiomyopathy |c edited by E. E. van der Wall, P. K. Blanksma, M. G. Niemeyer, A. M. J. Paans |
264 | 1 | |a Dordrecht |b Springer Netherlands |c 1995 | |
300 | |a 1 Online-Ressource (XVI, 256 p) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Developments in Cardiovascular Medicine |v 166 | |
520 | |a Myocardial viability has become one of the most important issues in clinical cardiology. In particular, absence or presence of viability may be decisive in patient management, and the decision to perform angioplasty (PTCA) or bypass surgery (CABG) is frequently based on the accurate assessment of viability. Although echocardiography and conventional nuclear medicine techniques may provide valuable information on viability, positron emission tomography (PET) is currently considered to be the gold standard for the assessment of myocardial viability. The simultaneous evaluation of myocardial metabolism and perfusion allows precise delineation and accurate quantification of residual myocardial viability in affected regions. In addition, accurate quantification of myocardial perfusion alone may provide insight into the basic mechanisms of syndrome X and may assist in the appropriate clarification of this clinically complicated, but frequently occurring phenomenon. Besides that, cardiac PET may deepen our insight into metabolism and perfusion of cardiac muscle disease, particularly in hypertrophic cardiomyopathy. Furthermore, receptor imaging studies with PET will become important as the study of cardiac neurohumoral regulation in heart failure has gained in interest. Cardiac Positron Emission Tomography: Viability, Perfusion, Receptors and Cardiomyopathy describes the most recent developments in cardiac PET as these are related to myocardial viability and myocardial perfusion studies of syndrome X. The value of PET for receptor imaging and cardiac muscle disease is also discussed. For cardiologists, nuclear medicine physicians, radiochemists, physiologists, technicians and basic researchers interested in understanding the most recent achievements in cardiovascular PET. | ||
650 | 4 | |a Cardiology | |
650 | 4 | |a Cardiology | |
650 | 0 | 7 | |a Positronen-Emissions-Tomografie |0 (DE-588)4129799-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Herzkrankheit |0 (DE-588)4024663-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Herz |0 (DE-588)4024632-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Herzfunktion |0 (DE-588)4159661-4 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1995 |z Groningen |2 gnd-content | |
689 | 0 | 0 | |a Herzkrankheit |0 (DE-588)4024663-2 |D s |
689 | 0 | 1 | |a Positronen-Emissions-Tomografie |0 (DE-588)4129799-4 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Herz |0 (DE-588)4024632-2 |D s |
689 | 1 | 1 | |a Positronen-Emissions-Tomografie |0 (DE-588)4129799-4 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Herzfunktion |0 (DE-588)4159661-4 |D s |
689 | 2 | 1 | |a Positronen-Emissions-Tomografie |0 (DE-588)4129799-4 |D s |
689 | 2 | |5 DE-604 | |
700 | 1 | |a Wall, E. E. van der |4 edt | |
700 | 1 | |a Blanksma, P. K. |4 edt | |
700 | 1 | |a Niemeyer, M. G. |4 edt | |
700 | 1 | |a Paans, A. M. J. |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789401040143 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780792334729 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789401100243 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-94-011-0023-6 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_1990/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031524249 | ||
966 | e | |u https://doi.org/10.1007/978-94-011-0023-6 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180478957191168 |
---|---|
any_adam_object | |
author2 | Wall, E. E. van der Blanksma, P. K. Niemeyer, M. G. Paans, A. M. J. |
author2_role | edt edt edt edt |
author2_variant | e e v d w eevd eevdw p k b pk pkb m g n mg mgn a m j p amj amjp |
author_facet | Wall, E. E. van der Blanksma, P. K. Niemeyer, M. G. Paans, A. M. J. |
building | Verbundindex |
bvnumber | BV046144065 |
classification_rvk | YR 5000 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-94-011-0023-6 (OCoLC)1119081868 (DE-599)BVBBV046144065 |
dewey-full | 616.12 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.12 |
dewey-search | 616.12 |
dewey-sort | 3616.12 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-94-011-0023-6 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04305nmm a2200637zcb4500</leader><controlfield tag="001">BV046144065</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1995 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789401100236</subfield><subfield code="9">978-94-011-0023-6</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-94-011-0023-6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-94-011-0023-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119081868</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046144065</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.12</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YR 5000</subfield><subfield code="0">(DE-625)154117:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cardiac Positron Emission Tomography</subfield><subfield code="b">Viability, Perfusion, Receptors and Cardiomyopathy</subfield><subfield code="c">edited by E. E. van der Wall, P. K. Blanksma, M. G. Niemeyer, A. M. J. Paans</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Dordrecht</subfield><subfield code="b">Springer Netherlands</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XVI, 256 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Developments in Cardiovascular Medicine</subfield><subfield code="v">166</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Myocardial viability has become one of the most important issues in clinical cardiology. In particular, absence or presence of viability may be decisive in patient management, and the decision to perform angioplasty (PTCA) or bypass surgery (CABG) is frequently based on the accurate assessment of viability. Although echocardiography and conventional nuclear medicine techniques may provide valuable information on viability, positron emission tomography (PET) is currently considered to be the gold standard for the assessment of myocardial viability. The simultaneous evaluation of myocardial metabolism and perfusion allows precise delineation and accurate quantification of residual myocardial viability in affected regions. In addition, accurate quantification of myocardial perfusion alone may provide insight into the basic mechanisms of syndrome X and may assist in the appropriate clarification of this clinically complicated, but frequently occurring phenomenon. Besides that, cardiac PET may deepen our insight into metabolism and perfusion of cardiac muscle disease, particularly in hypertrophic cardiomyopathy. Furthermore, receptor imaging studies with PET will become important as the study of cardiac neurohumoral regulation in heart failure has gained in interest. Cardiac Positron Emission Tomography: Viability, Perfusion, Receptors and Cardiomyopathy describes the most recent developments in cardiac PET as these are related to myocardial viability and myocardial perfusion studies of syndrome X. The value of PET for receptor imaging and cardiac muscle disease is also discussed. For cardiologists, nuclear medicine physicians, radiochemists, physiologists, technicians and basic researchers interested in understanding the most recent achievements in cardiovascular PET.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Positronen-Emissions-Tomografie</subfield><subfield code="0">(DE-588)4129799-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Herzkrankheit</subfield><subfield code="0">(DE-588)4024663-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Herz</subfield><subfield code="0">(DE-588)4024632-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Herzfunktion</subfield><subfield code="0">(DE-588)4159661-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1995</subfield><subfield code="z">Groningen</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Herzkrankheit</subfield><subfield code="0">(DE-588)4024663-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Positronen-Emissions-Tomografie</subfield><subfield code="0">(DE-588)4129799-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Herz</subfield><subfield code="0">(DE-588)4024632-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Positronen-Emissions-Tomografie</subfield><subfield code="0">(DE-588)4129799-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Herzfunktion</subfield><subfield code="0">(DE-588)4159661-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Positronen-Emissions-Tomografie</subfield><subfield code="0">(DE-588)4129799-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wall, E. E. van der</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Blanksma, P. K.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Niemeyer, M. G.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Paans, A. M. J.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789401040143</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780792334729</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9789401100243</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-94-011-0023-6</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031524249</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-94-011-0023-6</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1995 Groningen gnd-content |
genre_facet | Konferenzschrift 1995 Groningen |
id | DE-604.BV046144065 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:24Z |
institution | BVB |
isbn | 9789401100236 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031524249 |
oclc_num | 1119081868 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (XVI, 256 p) |
psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
publishDate | 1995 |
publishDateSearch | 1995 |
publishDateSort | 1995 |
publisher | Springer Netherlands |
record_format | marc |
series2 | Developments in Cardiovascular Medicine |
spelling | Cardiac Positron Emission Tomography Viability, Perfusion, Receptors and Cardiomyopathy edited by E. E. van der Wall, P. K. Blanksma, M. G. Niemeyer, A. M. J. Paans Dordrecht Springer Netherlands 1995 1 Online-Ressource (XVI, 256 p) txt rdacontent c rdamedia cr rdacarrier Developments in Cardiovascular Medicine 166 Myocardial viability has become one of the most important issues in clinical cardiology. In particular, absence or presence of viability may be decisive in patient management, and the decision to perform angioplasty (PTCA) or bypass surgery (CABG) is frequently based on the accurate assessment of viability. Although echocardiography and conventional nuclear medicine techniques may provide valuable information on viability, positron emission tomography (PET) is currently considered to be the gold standard for the assessment of myocardial viability. The simultaneous evaluation of myocardial metabolism and perfusion allows precise delineation and accurate quantification of residual myocardial viability in affected regions. In addition, accurate quantification of myocardial perfusion alone may provide insight into the basic mechanisms of syndrome X and may assist in the appropriate clarification of this clinically complicated, but frequently occurring phenomenon. Besides that, cardiac PET may deepen our insight into metabolism and perfusion of cardiac muscle disease, particularly in hypertrophic cardiomyopathy. Furthermore, receptor imaging studies with PET will become important as the study of cardiac neurohumoral regulation in heart failure has gained in interest. Cardiac Positron Emission Tomography: Viability, Perfusion, Receptors and Cardiomyopathy describes the most recent developments in cardiac PET as these are related to myocardial viability and myocardial perfusion studies of syndrome X. The value of PET for receptor imaging and cardiac muscle disease is also discussed. For cardiologists, nuclear medicine physicians, radiochemists, physiologists, technicians and basic researchers interested in understanding the most recent achievements in cardiovascular PET. Cardiology Positronen-Emissions-Tomografie (DE-588)4129799-4 gnd rswk-swf Herzkrankheit (DE-588)4024663-2 gnd rswk-swf Herz (DE-588)4024632-2 gnd rswk-swf Herzfunktion (DE-588)4159661-4 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1995 Groningen gnd-content Herzkrankheit (DE-588)4024663-2 s Positronen-Emissions-Tomografie (DE-588)4129799-4 s DE-604 Herz (DE-588)4024632-2 s Herzfunktion (DE-588)4159661-4 s Wall, E. E. van der edt Blanksma, P. K. edt Niemeyer, M. G. edt Paans, A. M. J. edt Erscheint auch als Druck-Ausgabe 9789401040143 Erscheint auch als Druck-Ausgabe 9780792334729 Erscheint auch als Druck-Ausgabe 9789401100243 https://doi.org/10.1007/978-94-011-0023-6 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Cardiac Positron Emission Tomography Viability, Perfusion, Receptors and Cardiomyopathy Cardiology Positronen-Emissions-Tomografie (DE-588)4129799-4 gnd Herzkrankheit (DE-588)4024663-2 gnd Herz (DE-588)4024632-2 gnd Herzfunktion (DE-588)4159661-4 gnd |
subject_GND | (DE-588)4129799-4 (DE-588)4024663-2 (DE-588)4024632-2 (DE-588)4159661-4 (DE-588)1071861417 |
title | Cardiac Positron Emission Tomography Viability, Perfusion, Receptors and Cardiomyopathy |
title_auth | Cardiac Positron Emission Tomography Viability, Perfusion, Receptors and Cardiomyopathy |
title_exact_search | Cardiac Positron Emission Tomography Viability, Perfusion, Receptors and Cardiomyopathy |
title_full | Cardiac Positron Emission Tomography Viability, Perfusion, Receptors and Cardiomyopathy edited by E. E. van der Wall, P. K. Blanksma, M. G. Niemeyer, A. M. J. Paans |
title_fullStr | Cardiac Positron Emission Tomography Viability, Perfusion, Receptors and Cardiomyopathy edited by E. E. van der Wall, P. K. Blanksma, M. G. Niemeyer, A. M. J. Paans |
title_full_unstemmed | Cardiac Positron Emission Tomography Viability, Perfusion, Receptors and Cardiomyopathy edited by E. E. van der Wall, P. K. Blanksma, M. G. Niemeyer, A. M. J. Paans |
title_short | Cardiac Positron Emission Tomography |
title_sort | cardiac positron emission tomography viability perfusion receptors and cardiomyopathy |
title_sub | Viability, Perfusion, Receptors and Cardiomyopathy |
topic | Cardiology Positronen-Emissions-Tomografie (DE-588)4129799-4 gnd Herzkrankheit (DE-588)4024663-2 gnd Herz (DE-588)4024632-2 gnd Herzfunktion (DE-588)4159661-4 gnd |
topic_facet | Cardiology Positronen-Emissions-Tomografie Herzkrankheit Herz Herzfunktion Konferenzschrift 1995 Groningen |
url | https://doi.org/10.1007/978-94-011-0023-6 |
work_keys_str_mv | AT walleevander cardiacpositronemissiontomographyviabilityperfusionreceptorsandcardiomyopathy AT blanksmapk cardiacpositronemissiontomographyviabilityperfusionreceptorsandcardiomyopathy AT niemeyermg cardiacpositronemissiontomographyviabilityperfusionreceptorsandcardiomyopathy AT paansamj cardiacpositronemissiontomographyviabilityperfusionreceptorsandcardiomyopathy |